Annexon (ANNX) announced the appointment of William “BJ” Jones to its board of directors. He currently serves as chief commercial officer of NewAmsterdam Pharma Company (NAMS).
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANNX:
- Annexon (ANNX) Surges with Promising Phase 3 Results for Guillain-Barré Syndrome Treatment
- Annexon announces topline results from RWE study of ANX005 in GBS
- Annexon to present Phase 2 ARCHER DATA on ANX007
- Annexon Biosciences Reports Q3 Financial Results
- Annexon reports Q3 EPS (25c), consensus (27c)